Aeovian Pharmaceuticals Company
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Headquarters:
San Francisco, California, United States
Number Of Exists:
Series A
Total Funding:
37000000
Founded Date:
2012
Employee Number:
1-10
Last Funding Type:
Series A
Investor Type:
Early Stage Venture
Investors Number:
4
Last Funding Date:
2019
Technology:
NeuroTech
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
Biopharma, Biotechnology, Health Care, Pharmaceutical